Best of Lung Cancer Summit 2021
The Best of Lung Cancer Summit is a digital meeting and will be held on Friday, October 29, 2021. Chaired by Dr. Barbara Melosky and Dr. Paul Wheatley-Price, this year’s program will take the most significant lung cancer data from the 2021 ASCO, ESMO and World Lung conferences, and put it into context for oncology professionals. Speakers will review the latest research with in-depth analysis and discussion to improve the current standard of lung cancer care.
After taking part in this program, participants will be able to:
- Describe the current and future availability and application of immunotherapy in the treatment of lung cancer.
- Understand the latest strategies for managing lung cancer with radiation therapy and/or surgery.
- Discuss approaches for maximizing outcomes on the standard of care in the management of lung cancer using biomarker testing, targeted therapies and other new targets.
- Timezone: America/New_York
- Date: Friday, October 29, 2021
- Time: 9:00 am - 3:05 pm
Registration is complimentary for healthcare professionals and can be completed below.
Industry representatives (both sponsor and non-sponsor) can register by contacting Laura Davidson at email@example.com.
9:00 am – 9:45 am EDT
Eli Lilly Breakfast Symposium: Recent Advances in RET-altered NSCLC – Dr. Adrian Sacher with panelist, Dr. Brandon Sheffield
9:45 am – 10:00 am EDT
Welcome Address by Chairs – Dr. Barbara Melosky & Dr. Paul Wheatley-Price
10:00 am – 10:20 am EDT
Lung Cancer Screening for Never Smokers – Dr. Renelle Myers
10:20 am – 10:40 am EDT
National Screening Update – Ms. Erika Nicholson
10:40 am – 11:15 am EDT
Debate: Adjuvant vs. Neoadjuvant Treatment – Dr. Jonathan Spicer vs. Dr. Catherine Labbé
11:15 am – 11:25 am EDT
11:25 am – 12:00 pm EDT
Debate: Adjuvant Therapy – Is DFS a satisfactory end point? – Dr. David Stewart vs. Dr. Shantanu Banerji
12:00 pm – 12:30 pm EDT
12:30 pm – 1:15 pm EDT
Amgen Lunch Symposium: The race to target KRAS – Old Target in New Patients – Dr. Hossein Borghaei
1:15 pm – 2:15 pm EDT
Early Stage Small Cell Lung Cancer (Tumour Board)
- Surgery for Small Cell (Dr. Donna Maziak)
- Post Surgery Treatment (Dr. Stephanie Snow)
- Radiation for Small Cell (Dr. Mitchell Liu)
2:15 pm – 2:25 pm EDT
2:25 pm – 2:55 pm EDT
Systemic Small Cell – Dr. Kevin Jao
2:55 pm – 3:05 pm EDT
Closing Remarks by Chairs – Dr. Barbara Melosky & Dr. Paul Wheatley-Price
About the Faculty
Dr. Barbara Melosky
Dr. Melosky is a Clinical Professor of medicine at the University of British Columbia and a medical oncologist in Vancouver at the British Columbia Cancer Agency. Dr. Melosky specializes in the field of thoracic malignancy. She is head of the Lung Tumor Group at BC Cancer.
She sits on the Executive Lung Site Committee for Canadian Clinical Trials Group CTTG.Dr. Melosky chaired the Canadian Lung Cancer Conference for the last 21 years, which is attended by over 500 participants. She organizes and chairs the Lung Cancer Journal Club. She is chair and created the British Columbia Lung Cancer Biobank.
She is published extensively and is considered a national and international expert in thoracic malignancies.
Dr. Paul Wheatley-Price is an Associate Professor in the Department of Medicine at the University of Ottawa, and a medical oncologist at The Ottawa Hospital Cancer Centre, specializing in the treatment of thoracic malignancies and carcinoma of unknown primary.
Dr. Wheatley-Price is a Past President and ongoing Board member for Lung Cancer Canada. Dr. Wheatley-Price attended medical school in the UK, at the University of St. Andrews (1991-1994) and the University of Manchester (1994 – 1997).
He received specialist medical oncology training in Wellington, New Zealand, in London at the Royal Free Hospital, Guy’s and St. Thomas’ Hospitals and St. George’s Hospital, and as a Fellow in Lung Cancer Research at Princess Margaret Cancer Centre in Toronto.
He has been in Ottawa since 2009.
For sponsorship-related inquiries, please contact Bernadette Gregoris at firstname.lastname@example.org.